Literature DB >> 30390294

Function and regulation of apelin/APJ system in digestive physiology and pathology.

Zhen Huang1,2, Xuling Luo1, Meiqing Liu1, Linxi Chen1.   

Abstract

Apelin is an endogenous ligand of seven-transmembrane G-protein-coupled receptor APJ. Apelin and APJ are distributed in various tissues, including the heart, lung, liver, kidney, and gastrointestinal tract and even in tumor tissues. Studies show that apelin messenger RNA is widely expressed in gastrointestinal (GI) tissues, including stomach and small intestine, which is closely correlated with GI function. Thus, the apelin/APJ system may exert a broad range of activities in the digestive system. In this paper, we review the role of the apelin/APJ system in the digestive system in physiological conditions, such as gastric acid secretion, control of appetite and food intake, cell proliferation, cholecystokinin secretion and histamine release, gut-brain axis, GI motility, and others. In pathological conditions, the apelin/APJ system plays an important role in the healing process of stress gastric injury, the clinical features and prognosis of patients with gastric cancers, the reduction of inflammatory response to enteritis and pancreatitis, the mediation of liver fibrogenesis, the promotion of liver damage, the inhibition of liver regeneration, the contribution of splanchnic neovascularization in portal hypertension, the treatment of colon cancer, and GI oxidative damage. Overall, the apelin/APJ system plays diversified functions and regulatory roles in digestive physiology and pathology. Further exploration of the relationship between the apelin/APJ system and the digestive system will help to find new and effective drugs for treating and alleviating the pain of digestive diseases.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Apelin/APJ; digestive; diseases; gastrointestinal (GI); tumor

Mesh:

Substances:

Year:  2018        PMID: 30390294     DOI: 10.1002/jcp.27720

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Breast milk apelin level increases with maternal obesity and high-fat feeding during lactation.

Authors:  Lucie Marousez; Sandy Hanssens; Laura Butruille; Céline Petit; Charlène Pourpe; Capucine Besengez; Thameur Rakza; Laurent Storme; Philippe Deruelle; Jean Lesage; Delphine Eberlé
Journal:  Int J Obes (Lond)       Date:  2021-02-16       Impact factor: 5.095

2.  Apelin-13 inhibits apoptosis and excessive autophagy in cerebral ischemia/reperfusion injury.

Authors:  Zi-Qi Shao; Shan-Shan Dou; Jun-Ge Zhu; Hui-Qing Wang; Chun-Mei Wang; Bao-Hua Cheng; Bo Bai
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

Review 3.  Involvement of Novel Adipokines, Chemerin, Visfatin, Resistin and Apelin in Reproductive Functions in Normal and Pathological Conditions in Humans and Animal Models.

Authors:  Anthony Estienne; Alice Bongrani; Maxime Reverchon; Christelle Ramé; Pierre-Henri Ducluzeau; Pascal Froment; Joëlle Dupont
Journal:  Int J Mol Sci       Date:  2019-09-09       Impact factor: 5.923

4.  Next Generation Sequencing Identify Rare Copy Number Variants in Non-syndromic Patent Ductus Arteriosus.

Authors:  Bo Chen; Aiping Hou; Lin Zhao; Ying Liu; Xin Shi; Bowen Du; Yu Yu; Pengjun Zhao; Ying Gao
Journal:  Front Genet       Date:  2020-11-12       Impact factor: 4.599

5.  Pretreatment with Lactobacillus fermentum XY18 Relieves Gastric Injury Induced by HCl/Ethanol in Mice via Antioxidant and Anti-Inflammatory Mechanisms.

Authors:  Ranran Wang; Kexiang Zhou; Rongrong Xiong; Yi Yang; Ruokun Yi; Jing Hu; Wei Liao; Xin Zhao
Journal:  Drug Des Devel Ther       Date:  2020-12-30       Impact factor: 4.162

Review 6.  Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis.

Authors:  Pedro Melgar-Lesmes; Meritxell Perramon; Wladimiro Jiménez
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

7.  Apelin‑13 alleviates diabetic nephropathy by enhancing nitric oxide production and suppressing kidney tissue fibrosis.

Authors:  Zhuo Gao; Xin Zhong; Ying-Xia Tan; Dong Liu
Journal:  Int J Mol Med       Date:  2021-07-19       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.